Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.73 (
urokinase-type plasminogen activator
)
10,685
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A protein which enhanced
urokinase-type plasminogen activator
(
u-PA
) activity was purified from the extracts of extracellular matrix of highly metastatic cell line
HAL
-8 derived from human lung adenocarcinoma. The protein showed a single band with molecular weight of 65 kDa after the purification by Sephadex G-150 and diethylaminoethyl-cellulose followed by reversed phase separation in a high performance liquid chromatography system. The purified protein in the immobilized conditions enhanced
u-PA
activity in both plasminogen activation and S-2444 amidolysis by 4.6- and 2.8-fold increases in the second order rate constants (Kcat/K(m)), respectively. This protein was related to neither plasminogen nor single-chain
u-PA
by the immunological studies and with respect to retention time on reversed phase analysis. These results suggest that the purified material acts as an enhancer of
u-PA
in extracellular matrix of the cancer cells, inducing an effective tissue destruction and cell invasion and possessing a highly metastatic potential.
...
PMID:Enhanced urokinase-type plasminogen activator activity by extracellular matrix protein obtained from highly metastatic human lung adenocarcinoma cell line. 887 37
The effects of heat treatment on the viability and fibrinolytic potential of four cultured human carcinoma cell lines, fibrosarcoma cells (HT-1080), lung adenocarcinoma cells with highly metastatic potential (
HAL
-8), melanoma cells (Bowes) and osteosarcoma cells (NY), determined by measuring their levels of
urokinase-type plasminogen activator
(
u-PA
) and its specific receptor (u-PAR), were investigated by comparing them with those of human umbilical vein endothelial cells (HUVECs). HUVECs incubated at 43 degrees C for 120 min exhibited no decrease in viability but exhibited an increase in both
u-PA
and u-PAR. HT-1080 and
HAL
-8 showed a moderately high heat-resistance (viability, 60-90%) that correlated with the reduction of u-PAR but not
u-PA
. On the other hand, Bowes and NY cells, with poor heat-resistance (viability, 20-50%), exhibited stronger cell-associated
u-PA
activity when they survived at 43 degrees C for 120 min. Since the
u-PA
/u-PAR system is directly involved in the invasiveness and metastatic potential of carcinoma cells, hyperthermia would alter the biological activity of these carcinoma cells.
...
PMID:Effect of hyperthermia on the viability and the fibrinolytic potential of human cancer cell lines. 1080 68